--Private-equity group EQT is reviving plans for an initial public offering of dermatology company Galderma that could value it at around $20 billion, the Financial Times reports, citing unnamed sources.

--The company--which was spun out of Nestle in 2019--could be listed in Switzerland as soon as the first half of this year, according to the FT.

--EQT declined to comment when contacted by Dow Jones Newswires. Galderma didn't immediately respond to a request for comment.


Full story: https://shorturl.at/dijF9


Write to Nina Kienle at nina.kienle@wsj.com


(END) Dow Jones Newswires

02-05-24 0343ET